Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13

Nature Communications(2014)10.1038/ncomms6671Source: DataRank Database

miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13 is a research paper published in Nature Communications (2014). On theSindex it has a DataRank of 7.8. It has been cited 183 times, with 167 citing works in its 1-hop citation network.

N/A

7.8DataRank · unranked

Scored on demand from live citation data

183 citations · 167 citing works in its network

Download PDF

Cite:

Linked data & code

geo

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (19 grants)OA: bronzeTopics (30)IDs (PubMed, PMC)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 10%Citation Network 90%

Base Score Contribution

0.782

From this paper's citation signal

Citation Network Contribution

7.0

From 157 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 167 citers.

MicroRNA-621 Acts as a Tumor Radiosensitizer by Directly Targeting SETDB1 in Hepatocellular Carcinoma
Molecular Therapy201873 citations22 referencesContributes 0.196
MicroRNA miR-374, a potential radiosensitizer for carbon ion beam radiotherapy
Oncology Reports201620 citations17 referencesContributes 0.179
The silent healer: miR-205-5p up-regulation inhibits epithelial to mesenchymal transition in colon cancer cells by indirectly up-regulating E-cadherin expression
Cell Death and Disease201883 citations29 referencesContributes 0.153
miR-424 acts as a tumor radiosensitizer by targeting aprataxin in cervical cancer
Oncotarget201640 citations25 referencesContributes 0.149
Inhibiting ubiquitin conjugating enzyme E2 N by microRNA‐590‐3p reduced cell growth of cervical carcinoma
The Kaohsiung Journal of Medical Sciences202018 citations21 referencesContributes 0.140

Authors (19)

Li Wang ORCID,Cristian Rodriguez-Aguayo,Yuan Yuan ORCID,Bisrat G. Debeb ORCID,Dahu Chen

Live enrichment

PubMed:25476932 PMC:PMC4377070

NIGMS NIH HHS

Grant: R43 GM100777

NCI NIH HHS

Grant: U54CA151668

NCI NIH HHS

Grant: R00 CA138572

NCI NIH HHS

Grant: R01 CA166051

NCI NIH HHS

Grant: R01CA181029

NIGMS NIH HHS

Grant: R44 GM086937

NCI NIH HHS

Grant: P50 CA100632

NCI NIH HHS

Grant: R01 CA164346

NCI NIH HHS

Grant: P30 CA016672

NCI NIH HHS

Grant: CA100632

National Institutes of Health

Grant: 3P50CA100632-06S1

University of Texas M.D. Anderson Cancer Center SPORE - Leukemia

National Institutes of Health

Grant: 5R01CA181029-04

Epithelial-mesenchymal transition regulators in radioresistance and DNA repair

National Institutes of Health

Grant: 1R43GM100777-01

New Building Blocks for the Synthesis of Modified RNAs

National Institutes of Health

Grant: 5R00CA138572-05

Role of microRNAs in malignant progression

National Institutes of Health

Grant: 5R01CA166051-03

Regulation of metastasis and epithelial-mesenchymal transition by microRNAs

National Institutes of Health

Grant: 3P30CA016672-41S4

Cancer Center Support (CORE) Grant

National Institutes of Health

Grant: 1R01CA164346-01A1

CHARACTERIZATION AND TARGETED THERAPY OF T-ALL DEFICIENT FOR PTEN AND INK4A/ARF

National Institutes of Health

Grant: 2R44GM086937-02

New Reagents for RNA-based Therapeutic Technologies

National Institutes of Health

Grant: 5U54CA151668-03

Biomathematics Core

bronzeLicense: Springer Nature TDM

publisherhttps://www.nature.com/articles/ncomms6671.pdf

publisherhttps://www.nature.com/articles/ncomms6671

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/4377070

Europe_PMChttps://europepmc.org/articles/PMC4377070

Europe_PMChttps://europepmc.org/articles/PMC4377070?pdf=render

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Cell Line, TumorHumansNeoplasmsUbiquitin-Conjugating EnzymesHomeodomain ProteinsTranscription FactorsMicroRNAsDNA RepairDown-RegulationGene Expression Regulation, NeoplasticRadiation ToleranceAtaxia Telangiectasia Mutated ProteinsZinc Finger E-box-Binding Homeobox 1

Keywords

Homeodomain ProteinsDNA RepairDown-RegulationZinc Finger E-box-Binding Homeobox 1Ataxia Telangiectasia Mutated ProteinsRadiation ToleranceArticleGene Expression Regulation, NeoplasticMicroRNAsCell Line, TumorNeoplasmsUbiquitin-Conjugating EnzymesHumansTranscription Factors

Sustainable Development Goals

SDG 3: 3. Good healthSDG 13: 13. Climate action

miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13

FAIR Checklist

DataRank Breakdown

Top 5 citers driving the network score

Authors (19)

Funding (19 grants)

Open Access

Topics

Annotations (Europe PMC)